Acadia Healthcare Company, Inc.
For the period ended Dec 31, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 27, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Acadia Healthcare Company, Inc. | |
| By: | /s/ Debra K. Osteen |
| Debra K. Osteen | |
| Chief Executive Officer and Director |
Dated: February 26, 2026
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Debra K. OsteenDebra K. Osteen | Chief Executive Officer and Director (Principal Executive Officer) | February 26, 2026 |
| /s/ Todd YoungTodd Young | Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | February 26, 2026 |
| /s/ Reeve B. WaudReeve B. Waud | Chairman of the Board | February 26, 2026 |
| /s/ Jason R. BernhardJason R. Bernhard | Director | February 26, 2026 |
| /s/ E. Perot BissellE. Perot Bissell | Director | February 26, 2026 |
| /s/ Michael J. FucciMichael J. Fucci | Director | February 26, 2026 |
| /s/ Vicky B. GreggVicky B. Gregg | Director | February 26, 2026 |
| /s/ William F. GriecoWilliam F. Grieco | Director | February 26, 2026 |
| /s/ Patrice A. HarrisPatrice A. Harris | Director | February 26, 2026 |
| /s/ R. David KellyR. David Kelly | Director | February 26, 2026 |
| /s/ Wade D. MiquelonWade D. Miquelon | Director | February 26, 2026 |
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| PAGE | |
| Management’s Report on Internal Control Over Financial Reporting | F-2 |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB: 42) | F-3 |
| Report of Independent Registered Public Accounting Firm | F-4 |
| Consolidated Balance Sheets at December 31, 2025 and 2024 | F-6 |
| Consolidated Statements of Operations for the years ended December 31, 2025, 2024 and 2023 | F-7 |
| Consolidated Statements of Equity for the years ended December 31, 2025, 2024 and 2023 | F-8 |
| Consolidated Statements of Cash Flows for the years ended December 31, 2025, 2024 and 2023 | F-9 |
| Notes to Consolidated Financial Statements | F-10 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.